--- title: "Tian An Medicare Limited (00383.HK)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/00383.HK.md" symbol: "00383.HK" name: "Tian An Medicare Limited" industry: "Health Care Facilities" --- # Tian An Medicare Limited (00383.HK) | Item | Detail | |------|--------| | Industry | Health Care Facilities | | Location | HK Market | | Website | [www.tiananmedicare.com.hk](https://www.tiananmedicare.com.hk) | ## Company Profile Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People’s Republic of China and Hong Kong. It operates through Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments segments. The compan... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-16T04:30:10.000Z **Overall: C (0.52)** **Industry**: Health Care Facilities | Metric | Value | |--------|-------| | Industry Ranking | 9 / 18 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -2.49% | | | Net Profit YoY | -45.49% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.55 | | | Dividend Ratio | 2.16% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 1.00B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 1.59B | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 1.05% | D | | Profit Margin | 1.20% | C | | Gross Margin | 19.15% | D | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -2.49% | D | | Net Profit YoY | -45.49% | D | | Total Assets YoY | -1.21% | D | | Net Assets YoY | 0.42% | C | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 8321.38% | A | | OCF YoY | -2.49% | D | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.46 | C | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 44.82% | C | ```chart-data:radar { "title": "Longbridge Financial Score - Tian An Medicare Limited", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "1.05%", "rating": "D" }, { "name": "Profit Margin", "value": "1.20%", "rating": "C" }, { "name": "Gross Margin", "value": "19.15%", "rating": "D" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-2.49%", "rating": "D" }, { "name": "Net Profit YoY", "value": "-45.49%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-1.21%", "rating": "D" }, { "name": "Net Assets YoY", "value": "0.42%", "rating": "C" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "8321.38%", "rating": "A" }, { "name": "OCF YoY", "value": "-2.49%", "rating": "D" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.46", "rating": "C" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "44.82%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | SAINT BELLA (HK.2508) | D | A | B | B | B | B | | 02 | HYGEIA HEALTH (HK.6078) | C | D | C | B | C | C | | 03 | BAYZED HEALTH (HK.2609) | D | C | C | B | D | C | | 04 | CR MEDICAL (HK.1515) | C | C | B | C | C | C | | 05 | CHAOJU EYE CARE (HK.2219) | B | D | C | A | C | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 52.64 | 11/19 | 56.69 | 49.91 | 29.38 | | PB | 0.55 | 4/19 | 0.61 | 0.54 | 0.47 | | PS (TTM) | 0.63 | 10/19 | 0.69 | 0.61 | 0.52 | | Dividend Yield | 2.16% | 8/19 | 2.22% | 2.00% | 1.35% | ## References - [Company Overview](https://longbridge.com/en/quote/00383.HK/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/00383.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/00383.HK/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.